GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Total Equity

Senzime AB (OSTO:SEZI) Total Equity : kr352.97 Mil (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Total Equity?

Senzime AB's total equity for the quarter that ended in Mar. 2024 was kr352.97 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Senzime AB Total Equity Historical Data

The historical data trend for Senzime AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Total Equity Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.97 231.35 150.58 261.90 375.48

Senzime AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 313.40 283.91 307.88 375.48 352.97

Senzime AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Senzime AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=433.542-58.065
=375.48

Senzime AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=409.849-56.876
=352.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB Total Equity Related Terms

Thank you for viewing the detailed overview of Senzime AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Senzime AB (OSTO:SEZI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Total Equity
Comparable Companies
OSTO:BRAIN OSTO:MNTC OSTO:PRO OSTO:INTEG B OSTO:STIL OSTO:PAX OSTO:CRAD B OSTO:SPEC OSTO:OSSD OSTO:BOUL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
SNZZF:USA 6YC:Germany
Address
Ulls vag 41, Uppsala, SWE, 756 51
Website
https://www.senzime.com
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines